The Food and Drug Administration and the drug maker released documents before an advisory committee to the agency meets later this week to discuss whether to recommend emergency authorization of Moderna boosters.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register. By continuing to use this site, you are consenting to our use of cookies.